Novel-Mechanism Antibacterials And Microbiome-Friendly Agents Now Key For Summit Therapeutics

 
• By John Davis

Rare genetic disorders are no longer in the clinical development mix at Summit, which is hunkering down on identifying novel mechanisms of action for new antibacterials, including the discovery of much-needed agents for gonorrhea and microbiome-friendly agents for gut infections.

Gonorhoeae
A novel-mechanism agent for gonorrhea has been identified by Summit Therapeutics • Source: Shutterstock

More from Anti-infective

More from Therapy Areas